Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional american joint committee on cancer melanoma staging database

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2199-2205

  Thompson, John F ^{a,b,c,d,e,f,g,h}   Soong, Seng Jaw ^{a,b,c,d,e,f,g,h}   Balch, Charles M ^{a,b,c,d,e,f,g,h}   Gershenwald, Jeffrey E ^{a,b,c,d,e,f,g,h}   Ding, Shouluan ^{a,b,c,d,e,f,g,h}   Coit, Daniel G ^{a,b,c,d,e,f,g,h}   Flaherty, Keith T ^{a,b,c,d,e,f,g,h}   Gimotty, Phyllis A ^{a,b,c,d,e,f,g,h}   Johnson, Timothy ^{a,b,c,d,e,f,g,h}   Johnson, Marcella M ^{a,b,c,d,e,f,g,h}   Leong, Stanley P ^{a,b,c,d,e,f,g,h}   Ross, Merrick I ^{a,b,c,d,e,f,g,h}   Byrd, David R ^{a,b,c,d,e,f,g,h}   Cascinelli, Natale ^{a,b,c,d,e,f,g,h}   Cochran, Alistair J ^{a,b,c,d,e,f,g,h}   Eggermont, Alexander M ^{a,b,c,d,e,f,g,h}   McMasters, Kelly M ^{a,b,c,d,e,f,g,h}   Mihm Jr , Martin C ^{a,b,c,d,e,f,g,h}   Morton, Donald L ^{a,b,c,d,e,f,g,h}   Sondak, Vernon K ^{a,b,c,d,e,f,g,h}  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS RATE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; ULCER;

DATABASES, FACTUAL; HUMANS; KAPLAN-MEIER ESTIMATE; MELANOMA; MITOSIS; MITOTIC INDEX; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS;

EID: 79957929511     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.5812     Document Type: Article

References (30)

1. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001 (Pubitemid 32786276)
2. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001 (Pubitemid 32786275)
3. Retsas S, Henry K, Mohammed MQ, et al: Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): Validation in a cohort of 1284 patients. Eur J Cancer 38:511-516, 2002 (Pubitemid 34185390)
4. Azzola MF, Shaw HM, Thompson JF, et al: Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3,661 patients from a single center. Cancer 97:1488-1498, 2003 (Pubitemid 36297779)
5. Scolyer RA, Shaw HM, Thompson JF, et al: Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 27:1571-1576, 2003 (Pubitemid 37486620)
6. Francken AB, Shaw HM, Thompson JF, et al: The prognostic importance of tumor mitotic rate confirmed in 1,317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11:426-433, 2004 (Pubitemid 40486754)
7. Gimotty PA, Guerry D, Ming ME, et al: Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 22:3668-3676, 2004 (Pubitemid 41095205)
8. Sondak VK, Taylor JM, Sabel MS, et al: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11:247-258, 2004 (Pubitemid 40486764)
9. Thompson JF, Shaw HM: Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy? Ann Surg Oncol 11:233-235, 2004
10. Barnhill RL, Katzen J, Spatz A, et al: The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol 32:268-273, 2005 (Pubitemid 40459928)
11. Kesmodel SB, Karakousis GC, Botbyl JD, et al: Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 12:449-458, 2005 (Pubitemid 40884259)
12. Kruper LL, Spitz FR, Czerniecki BJ, et al: Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 107:2436-2445, 2006 (Pubitemid 44748527)
13. Scolyer RA, Thompson JF, Shaw HM, et al: The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. J Cutan Pathol 33:395-396, 2006
14. Balch CM, Gershenwald JE, Atkins MB, et al: Melanoma of the skin, in Edge SB, Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2009, pp 325-344
15. Balch CM, Gershenwald JE, Soong S-J, et al: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-6206, 2009
16. Balch CM, Gershenwald JE, Soong SJ, et al: Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: Comparison of nodal micrometastases versus macrometastases. J Clin Oncol 28:2452-2459, 2010
17. Thompson B, Austin R, Coory M, et al: Completeness of histopathology reporting of melanoma in a high-incidence geographical region. Dermatology 218:7-14, 2009
18. Santillan AA, Messina JL, Marzban SS, et al: Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: Impact on treatment decisions. J Clin Oncol 28:481-486, 2009
19. Cox DR: Regression models and life table. J R Stat Soc Series B Stat Methodol 34:187, 1972
20. Allen AC, Spitz S: Malignant melanoma: A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6:1-45, 1953
21. Attis MG, Vollmer RT: Mitotic rate in melanoma: A reexamination. Am J Clin Pathol 127:380-384, 2007 (Pubitemid 46806331)
22. Gimotty PA, Elder DE, Fraker DL, et al: Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 25:1129-1134, 2007 (Pubitemid 46596766)
23. Paek SC, Griffith KA, Johnson TM, et al: The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 109:100-108, 2007 (Pubitemid 46120199)
24. McGovern VJ, Cochran AJ, Van der Esch EP, et al: The classification of malignant melanoma, its histological reporting and registration: A revision of the 1972 Sydney classification. Pathology 18:12-21, 1986
25. McGovern VJ, Mihm MC Jr, Bailly C, et al: The classification of malignant melanoma and its histologic reporting. Cancer 32:1446-1457, 1973
26. Ellis PS, Whitehead R: Mitosis counting: A need for reappraisal. Hum Pathol 12:3-4, 1981 (Pubitemid 12239389)
27. Larsen TE, Little JH, Orell SR, et al: International pathologists congruence survey on quantitation of malignant melanoma. Pathology 12:245-253, 1980 (Pubitemid 10073663)
28. Heenan PJ, Matz LR, Blackwell JB, et al: Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 8:717-729, 1984 (Pubitemid 15222642)
29. Gershenwald JE, Soong SJ, Balch CM: 2010 TNM staging system for cutaneous melanoma...and beyond. Ann Surg Oncol 17:1475-1477, 2010
30. Caudle AS, Ross MI, Prieto VG, et al: Mitotic rate predicts sentinel lymph node involvement in melanoma: Impact of the 7th edition AJCC Melanoma Staging System. Ann Surg Oncol 17:S8, 2010 (suppl 1)